Recently, Sarah Whelan et al. found that CD112 was highly expressed on CD14+ cells (probably tumor-associated macrophages [TAMs] and monocytes) and CD45− cells (such as tumor epithelial cells and other nonimmune system cells) in breast, endometrial, ovarian, lung cancer, and liver cancer [33, 44]. Here, NECTIN2 is linked to neoplasm.